Board of Advisors
As a collective impact organization, we are only as strong as the network we engage. The Life Science Cares Boards of Advisors, all executives committed to our mission and model, ensure we are reaching broad and deep across the life science industry.
LSC Advisors are champions of our efforts within their organizations, connectors who leverage their network to help us grow, and contributors who ensure our operations and programs have the resources necessary to make an impact. Advisors are invited to help shape our strategy, by participating in Grant Review Committees, site visits and Advisor-only events.
BOSTON BOARD OF ADVISORS
Ram Aiyar
CEO – Korro Bio
Jeff Albers
Venture Partner – Atlas Venture
Rich Aldrich
General Partner – Longwood Fund
Pat Andrews
CEO – Sumitomo Dainippon Pharma Oncology
Imran Babar
Chief Business Officer – Cydan II Inc.
Mark Bamforth
Founder – Thairm Bio
Stephane Bancel
CEO – Moderna Therapeutics
Peter Barrett
Partner – Atlas Venture
Andy Beck
CEO – PathAIMarc Beer
Executive Chairman – BioTE
Paul Biondi
President – Pioneering Medicines
Kevin Bitterman
Partner – Atlas Venture
Mitch Bloom
Partner – Goodwin
Joshua Boger
Foundation & CEO (Former) – Vertex Pharmaceuticals
Mike Bonney
Executive Chair – Kaleido Biosciences
Bruce Booth
Partner – Atlas Venture
Katrine Bosley
Chairman of the Board – Arrakis Therapeutics
Aoife Brennan
CEO – Synlogic
Christine Brennan
Managing Director – Vertex Ventures
Michael Broxson
CEO – Q32 Bio
Paul Burgess
Chief Business Development and Strategic Operations Officer – Cerevel TherapeuticsStuart Cable
Partner – Goodwin
Pablo Cagnoni
CEO – Laronde
Stewart Campbell
Executive Vice President and President of North America – Ipsen
Thomas Carey
Founder & Partner – Perspective GroupAbbie Celniker
Partner – Third Rock Ventures
Bharatt Chowrira
President – PureTech Health
Tim Clackson
CEO – Theseus Pharmaceuticals
Mike Cloonan
President & CEO – Sionna Therapeutics
Hugh Cole
Chief Business Officer & Head of Corporate Development – Jounce Therapeutics
Kara Coluccio
Managing Partner – Perspective Group
Ron Cooper
President & CEO – Albireo Pharma
Zoltan Csimma
Senior Biotech Executive
Zoltan Csimma
Senior Biotech Executive
Elisabet De los Pinos
CEO – Aura Biosciences
Dee Dee DeMan
Chairman & CEO – Bench International
Tom DesRosier
Executive Vice President & Chief Legal Officer – Seres Therapeutics
Steven Dickman
Owner – CBT Advisors
Nova Diop
SVP & Co-Chair Diversity, Equity & Inclusion Executive Recruitment – Bench International
Dipal Doshi
President & CEO – Entrada TherapeuticsNeal Dunn
Partner – Trinity
Brian Dunphy
Partner – Mintz Levin
James Ehret
Managing Director, Life Sciences – Pacific Western BankPaul Enderle
Managing Director – Baycross Capital Group
Wendy Erler
VP, Head of STAR Patient Insights & Advocacy – Astra Zeneca, Alexion Rare Disease
Greg Erman
CEO – EmpiraMedElan Ezickson
Founding CEO – Sporos BioventuresDouglas Fambrough
CEO – Dicerna
Joe Farmer
President and Chief Operating Officer – Zenas BioPharma
James Foster
Chairman, President & CEO – Charles River Labs
Chris Gabrieli
Biotech VC (Retired)
Chris Gabrieli
Biotech VC (Retired)Nick Galakatos
Senior Managing Director – Blackstone
Jean George
General Partner – Lightstone VenturesHalley Gilbert
Chief Operating Officer & Chief Business Officer – Adagio Therapeutics
Michael Gilman
CEO – Arrakis Therapeutics
Glen Giovannetti
Global Biotechnology Leader (Retired) – EY
Michael Gladstone
Partner – Atlas VentureJohn Glasspool
CEO – Anthos Therapeutics
Jeff Goater
Venture Partner – The Column Group
Brian Goff
Chief Commercial and Global Operations Officer – Alexion
Arjun Goyal
Co-Founder and Managing Director – Vida Ventures
Mike Gray
Chief Financial & Chief Operating Officer – Imara Therapeutics
Dave Grayzel
Partner – Atlas Venture
Chris Guiffre
President & COO – Auron Therapeutics
Alex Harding
Entrepreneur in Residence – Atlas Venture
Penny Heaton
Global Therapeutic Head, Vaccines – Janssen
Michael Heffernan
Chairman – Collegium Pharmaceuticals
Bill Heiden
Healthcare Executive & Board Member
Bill Heiden
Healthcare Executive & Board Member
Jeffrey Hemman
Partner – PWC
Matt Henn
EVP, Chief Scientific Officer – Seres Therapeutics
Donna Higgins
Founder & CEO – The Higgins Group, Inc.Donna Higgins is Founder & CEO of The Higgins Group, Inc., one of the oldest and most successful search firms in the life sciences. Founded in 1998, the firm has grown exclusively through referrals as a result of Donna’s simple but powerful business philosophy: to develop lasting relationships with a select group of clients by doing great work. This drive for excellence infuses every aspect of the firm’s work due to a culture that values superior results, exceptional teamwork, and doing the right thing. Although her team has diverse backgrounds and experiences, all of The Higgins Group consultants, researchers, and associates share Donna’s energy, optimism, integrity, and grit.
Over her 30 years’ in the life sciences, Donna has gained a global reputation for her insight, expertise and integrity. Prior to starting her own firm, Donna was Vice President & Life Sciences Practice Lead for HFA International, where she built the life science practice by consistently exceeding her clients’ expectations. Before search, Donna worked on commercial teams at both ends of the life sciences spectrum, dividing a decade between Abbott Laboratories, a Fortune 50 pharmaceutical company, and Immunex, an emerging biotech company at the time.
Donna holds an MBA from Drexel University and a BA from Penn State University. Committed to lifelong learning, she joined the Coaching Certification Program at Columbia University to continue sharpening the strategic coaching she provides to clients and candidates. She is an Advisory Board member for Life Sciences Cares and the Association of Women Entrepreneurs, and a Board member for Big Brothers Big Sisters Independence Region and ACHIEVEability. She also serves as adjunct faculty at the Center for Positive Leadership, where she is a frequent speaker on women in business. Donna divides her time between the company’s Philadelphia and Boston offices.
Colin Hill
CEO, Chairman & Co-Founder – Aitia
Andrew Hirsch
CEO – C4 Therapeutics
Marnie Hoolahan
Managing Director – The Nemetz Group
Tim Hunt
Chief Culture and Corporate Affairs Officer – Xilio Therapeutics
Doug Ingram
CEO – Sarepta
Bruce Jacobs
Chief Financial Officer – Kymera TherapeuticsPierre Jacquet
Managing Director & Partner – L.E.K. Consulting
Brian Johnson
President – MassMEDICRosanna Kapeller
President & CEO – Rome Therapeutics
Ed Kaye, MD
CEO & Director – Stoke Therapeutics
Jason Kelly
CEO – Ginkgo Bio
Skip Kelly
Managing Director – JP Morgan
Doug Kerr
Chief Medical Officer – Generation Bio
Richard Kertzman
Managing Director – First Republic Bank
Reshma Kewalramani
CEO – Vertex Pharmaceuticals
Iya Khalil
Global Head of the AI Innovation Center – NovartisBjorn Koch
Senior Vice President, Wealth Management – UBS
Adam Koppel
Managing Director – Bain Capital Life Sciences
Joanne Kotz
President & CEO – Jnana Therapeutics
Nerissa Kreher
Chief Medical Offficer – Entrada Therapeutics
Art Krieg
Founder & CSO – Checkmate Pharmaceuticals
Michel Lagarde
Chief Operating Officer – Thermo Fisher
Peter Latham
CEO – Latham Biopharma Group
Donna Lavoie
CEO – LavoieHealthScienceJeff Leerink
CEO – SVB LeerinkJeff Leiden
Executive Chairman – Vertex PharmaceuticalsMark Levin
Partner – Third Rock Ventures
Daniel Lynch
Chairman – bluebird bio
Ivana Magovcevic-Liebisch
President & CEO – Vigil Neuroscience
Ankit Mahadevia
CEO – Spero Therapeutics
Mark Mallon
Biotech Executive
Mark Mallon
Biotech Executive
Hilary Malone
CEO – NewCo
Melissa Manno
SVP, Chief Human Resources Officer – Kiniksa
Eddie Martucci
Chair of the Board – Akili Interactive
Katie McCarthy
Managing Director – Halloran Consulting GroupGeoffrey McDonough
President & CEO – Generation Bio
Bill McVicar
Principal Consultant – BioStrat Consulting
David Meeker
President & CEO – Rhythm Pharmaceuticals
Dave Mello
President – The Richmond Group
Andrew Miller
Founder & COO – Karuna Therapeutics
Jill Milne
CEO – Astria Therapeutics
Cherie Myatt
Owner & Founder – The CM Group
Ted Myles
Chief Operating Officer & Chief Financial Officer – Scholar Rock
Marian Nakada
Vice President, Venture Investments – J&J
Amir Nashat
Partner – Polaris Partners
Susan Nemetz
Principal – The NemetzGroup
Mike O'Hara
Partner – Deloitte
Leslie Orne
Senior Partner & Chief Client Officer – Trinity Life Sciences
Douglas Pagan
Chief Financial Officer & Chief Operating Office – Jnana Therapeutics
Paris Panayiotopoulos
Partner and member of the Investment Committee – The Blackstone Group
Deval Patrick
Founder & Chairman – TogetherFUND
Joshua Philbrook
President – DENS Facility Services
Alice Pomponio
Managing Director – BrightEdge at American Cancer Society
Paula Ragan
CEO & President – X4 Pharmaceuticals
Jigar Raythatha
CEO – Constellation Pharma
Simon Read
CEO – Mariana Oncology
Laurence Reid
CEO – Decibel Therapeutics
Jason Rhodes
Partner – Atlas Venture
Dan Rosan
CBO & CFO – Ascidian Therapeutics
Rene Russo
CEO – Xilio Therapeutics
Tracey Sacco
Chief Commercial Officer – Scholar Rock
Nabiha Saklayen
Co-Founder & CEO – Cellino Biotech
Ian Sanderson
Chief Financial Officer – Nimbus Pharmaceuticals
Alicia Secor
President & CEO – Atalanta Therapeutics
Eric Shaff
President & CEO – Seres Therapeutics
Parag Shah
Founding Managing Director & CEO – K2 HealthVenturesDr. Phil Sharp
Bill Sibold
Executive Vice President, Head, Specialty Care – Sanofi
Nancy Simonian
CEO – Syros Pharmaceuticals
Samantha Singer
President & CEO – Abata Therapeutics
Otello Stampacchia
Founder – Omega Funds
Katie Terry
Vice President of Quality – Acceleron Pharma
Mary Thistle
Director
Mary Thistle
Director
Frank Thomas
Chief Financial Officer & Chief Business Officer – Orchard Therapeutics
Tamar Thompson
Head, Global Corporate Affairs – Alexion Pharmaceuticals
Courtney Thorne
Partner - Public Companies and Capital Markets – Cooley
Brian Tobin
CEO – Tobin Scientific
Mike Tomsicek
Chief Financial Officer – CRISPR Therapeutics
Ellen Travers
Partner – Chartwell Partners
Steven Tregay
Managing Partner – Mission Bio Capital
Samantha Truex
CEO – Upstream Bio
Ramani Varanasi
Managing Director – Revive Advisors
Rajeev Venkayya
CEO – Aerium Therapeutics
Christopher Viehbacher
President & CEO – Biogen
Jo Viney
CEO – Seismic Therapeutics
Shelia Violette
Co-Founder, Chief Scientific Officer & President of Research – Q32 Bio
Stefan Vitorovic
Co-Founder and Managing Director – Vida Ventures
Joseph Vittiglio
Chief Legal & Business Officer – bluebird bioJoe vonRickenbach
Co-Founder & Chairman – Parexel
Michel Vounatsos
CEO – Biogen
Kate Walsh
Managing Director, Life Science & Healthcare – HSBC Innovation Banking
Christoph Westphal
General Partner – Longwood Fund
Leslie Williams
Co-Founder, President & CEO – hC Bioscience
Cissy Young
Partner – Catalyst Advisors
Jill Zunshine
Senior Vice President and Head of Global Real Estate, Facilities, and Procurement
Takeda